FDA approves language-independent computer-assisted test to detect cognitive impairment

Subjects ” Alzheimer’s and dementia

The Food and Drug Administration (FDA) has cleared the CogniICA Integrated Cognitive Assessment (ICA) test for marketing as a medical device for the detection of cognitive impairments.

CogniICA is a 5-minute, language-independent cognitive assessment delivered on an iPad. The quick visual categorization test displays images of animals and prompts the user to classify the image as either animal or non-animal.

By using images of animals, the test avoids cultural or educational bias and can be used repeatedly without a learning effect. Data from the assessment can be integrated into existing electronic patient record systems.

Continue reading

In a study with 230 participants (95 healthy, 80 with mild cognitive impairment and 55 with mild Alzheimer’s disease) the ICA test showed “convergent validity with MoCA (Montreal Cognitive Assessment) (Pearson r = 0.58; P <.0001 ) and ACE (Addenbrookes Cognitive Examination) (r = 0.62; P <0.0001). “The results indicated that the ICA test was sensitive enough to detect cognitive impairment in the early stages and potentially as a monitoring tool in both the Clinic could be used remotely as well.

CogniICA is expected to be available nationwide in the United States in the coming months.

References

1. Cognitivity Neurosciences has FDA cleared ICA for commercial distribution throughout the US healthcare market. Press release. Cognitivity Neurosciences Ltd. October 20, 2021. Accessed October 22, 2021. https://cognetivity.com/cognitivity-neurosciences-granted-fda-clearance-for-commercial-distribution-of-ica-throughout-us-healthcare-market /.
2. Kalafatis C, Modarres MH, Apostolou P, et al. Validity and cultural generalizability of a 5-minute AI-based, computerized cognitive assessment in mild cognitive impairment and Alzheimer’s disease. Published online July 22, 2021. Frontiers in Psychiatry. doi.org/10.3389/fpsyt.2021.706695.

This article originally appeared on MPR

Subjects:

Alzheimer’s Disease Alzheimer’s Disease and Dementia Cognitive Impairment

Would you like to read more?

Please log in or register first to view this content.

Login Register

Open minded

Next post in Alzheimer’s and Dementia

Close

Include more information on FDA Approves Language-Independent Computational Test for Cognitive Impairment Detection

Loading…

Include more information on FDA Approves Language-Independent Computational Test for Cognitive Impairment Detection

Loading…

Include more information on FDA Approves Language-Independent Computational Test for Cognitive Impairment Detection

Loading…

Include more information on FDA Approves Language-Independent Computational Test for Cognitive Impairment Detection

Loading…

Would you like to see more content from Neurology Advisor?

Register now for free to access unlimited clinical news with personalized daily tips for you, Full-length features, case studies, conference coverage, and more.

{{login-button}} {{register-button}}

Would you like to read more?

Please log in or register first to view this content.

Login Register